Healthcare -
Biotechnology - NASDAQ - US
$ 3.345
1.36 %
$ 634 M
Market Cap
-7.78
P/E
ABUS - LONG-TERM DEBT
Long-term Debt ABUS - Arbutus Biopharma Corporation
8.3 M
LAST VALUE
92.83%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR